X4 Pharmaceuticals Inc.

XFOR | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.42

-$0.08 (-2.15%)

Sep 22, 2026, 12:35 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-79.2M	-37.45M	-101.17M	-93.87M	-88.7M	-62.13M
Depreciation & Amortization	1.28M	796K	419K	513K	1.89M	1.23M
Stock-Based Compensation	4.3M	8.2M	8.69M	5.2M	n/a	n/a
Other Working Capital	1.57M	6.85M	-890K	2.31M	-2.66M	-5.09M
Other Non-Cash Items	-9.42M	-105.13M	-4.8M	5.32M	17.4M	6.15M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-2.58M	2.68M	344K	5.74M	-1.5M	-4.06M
Operating Cash Flow	-85.62M	-130.9M	-96.51M	-77.1M	-70.91M	-58.82M
Capital Expenditures	-3M	-7.33M	-60K	-103K	-615K	-1.36M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-63.39M	-57.13M	-16.82M	n/a	n/a	n/a
Sales Maturities Of Investments	74.54M	26.45M	2M	n/a	n/a	n/a
Other Investing Acitivies	n/a	98M	n/a	n/a	n/a	n/a
Investing Cash Flow	8.15M	66.99M	-14.88M	-103K	-615K	-1.36M
Debt Repayment	n/a	20M	20.44M	-795K	n/a	12.39M
Common Stock Repurchased	n/a	n/a	n/a	n/a	-2M	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	98K	n/a	8.08M	-4.61M	n/a	-278K
Financial Cash Flow	238.63M	20.29M	88.52M	117.23M	74.25M	12.39M
Net Cash Flow	161.38M	-43.77M	-22.78M	39.92M	2.82M	-47.21M
Free Cash Flow	-88.62M	-138.23M	-96.57M	-77.21M	-71.52M	-60.18M
Adj. Free Cash Flow	-92.92M	-146.43M	-105.26M	-82.4M	-71.52M	-60.18M
Maintenance CapEx	n/a	n/a	-60K	-103K	-615K	n/a
Growth CapEx	-3M	-7.33M	n/a	n/a	n/a	-1.36M
Owner Earnings	-85.62M	-130.9M	-96.57M	-77.21M	-71.52M	-58.82M